Marketing-authorisation holder · Netherlands
Steriscience B.V.
9 medicines in 4 countries, as authorisation holder and marketer.
Loading your page…
Marketing-authorisation holder · Netherlands
9 medicines in 4 countries, as authorisation holder and marketer.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
9 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ERTAPENEM STERISCIENCEPolvere per concentrato per soluzione per infusione | Ertapenem | Italy | Authorised | |
| IMIPENEM/CILASTATINA STERISCIENCE 500 MG/500 MG POLVO PARA SOLUCION PARA PERFUSION EFG530,1 mg + 530,7 mg · Polvo para solución para perfusión | Imipenem, Cilastatin | Spain | Authorised | 2024 |
| IMIPENEM E CILASTATINA STERISCIENCESoluzione iniettabile o per infusione | Imipenem + cilastatina | Italy | Authorised | |
| Meropenem Steriscience 1000 mg, poeder voor oplossing voor injectie of infusiePoeder voor oplossing voor injectie of infusie | Meropenem | Netherlands | Authorised | 2022 |
| Meropenem Steriscience 1000 mg prašak za otopinu za injekciju/infuzijuPrašak za otopinu za injekciju / infuziju | Meropenem | Croatia | Not marketed | 2022 |
| MEROPENEM STERISCIENCE 2 G POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION2273, 20 mg · Polvo para solución inyectable y para perfusión | Meropenem | Spain | Authorised | 2025 |
| Meropenem Steriscience 500 mg, poeder voor oplossing voor injectie of infusiePoeder voor oplossing voor injectie of infusie | Meropenem | Netherlands | Authorised | 2022 |
| Meropenem Steriscience 500 mg prašak za otopinu za injekciju/infuzijuPrašak za otopinu za injekciju / infuziju | Meropenem | Croatia | Authorised | 2022 |
| MEROPENEM STERISCIENCE B.V.Polvere per soluzione iniettabile/per infusione | Meropenem | Italy | Authorised |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Italy | 3 | 3 | 0 | CompaniesAll medicines |
| Spain | 2 | 2 | 0 | CompaniesAll medicines |
| Croatia | 2 | 2 | 0 | CompaniesAll medicines |
| Netherlands | 2 | 2 | 0 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Report an error or request removalCorrections from the company itself are welcome.